SOPHiA GENETICS (SOPH) Market Capitalization (2021 - 2026)

SOPHiA GENETICS has disclosed Market Capitalization across 6 years of filings, most recently posting $395.2 million for Q2 2026.

• In Q2 2026, Market Capitalization rose 91.15% year-over-year to $395.2 million; the TTM figure through Jun 2026 stood at $395.2 million (up 91.15% YoY), while the FY2025 annual figure was $319.8 million, up 56.22% from the prior year.
• Market Capitalization came in at $395.2 million for Q2 2026 at SOPHiA GENETICS, up from $339.0 million in the prior quarter.
• In the past five years, Market Capitalization ranged from a high of $493.6 million in Q1 2022 to a low of $132.3 million in Q4 2022.
• Average Market Capitalization over 5 years is $275.9 million, with a median of $293.3 million recorded in 2023.
• Year-over-year, Market Capitalization slumped 85.3% in 2022 and jumped 132.2% in 2023.
• Over 5 years, Market Capitalization stood at $132.3 million in 2022, then jumped by 132.2% to $307.2 million in 2023, then slumped by 33.36% to $204.7 million in 2024, then surged by 56.22% to $319.8 million in 2025, then climbed by 23.55% to $395.2 million in 2026.
• Per Business Quant data, the three most recent Market Capitalization figures were $395.2 million in Q2 2026, $339.0 million in Q1 2026, and $319.8 million in Q4 2025.